SCHEMBL3846503

SCHEMBL3846503

C=Cc1ccc(NC(=O)c2ccc(-c3cnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cn34)cc2F)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 4/20 0.37
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
MET P08581 1/20 0.36
DYRK1A Q13627 3/20 0.34
KDR P35968 2/20 0.34
FGFR3 P22607 1/20 0.34
IKBKB O14920 3/20 0.34
EP300 Q09472 2/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
GSK3B P49841 2/20 0.33
MAPK1 P28482 1/20 0.33
WNT1 P04628 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3845229 0.89 SMN1; SMN2 (0.46) CLK1MKNK1MKNK2METSMN1; SMN2
SCHEMBL3847111 0.88 CLK1 (0.41) CLK1MKNK1MKNK2METDYRK1A
SCHEMBL3845914 0.84 MAPK1 (0.42) CLK1METDYRK1AMAPK1SMN1; SMN2
SCHEMBL3845025 0.84 SORT1 (0.41) CLK1MKNK1MKNK2METDYRK1A
SCHEMBL3846961 0.83 TRPV1 (0.47) CLK1METKDRFGFR3
SCHEMBL3849284 0.83 EPHB3 (0.38) CLK1MKNK1MKNK2METKDR
SCHEMBL3847490 0.83 MAPT (0.40) CLK1METMAPK1SMN1; SMN2KDM4E
SCHEMBL3847097 0.83 PRMT5 (0.38) CLK1MKNK1MKNK2METKDR
SCHEMBL3845909 0.82 EPHB3 (0.41) CLK1METKDRFGFR3SMN1; SMN2
SCHEMBL3848378 0.82 EPHB3 (0.38) CLK1MKNK1MKNK2DYRK1AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed